>latest-news

Thermo Fisher Launches Glacios 3 Cryo-TEM To Advance Structural Biology Research, With AI And Enhanced Lab Accessibility

Thermo Fisher Scientific launches Glacios 3 Cryo-TEM with enhanced imaging and AI workflows to advance structural biology research and improve lab accessibility for drug discovery studies

Breaking News

  • Apr 01, 2026

  • Vaibhavi M.

Thermo Fisher Launches Glacios 3 Cryo-TEM To Advance Structural Biology Research, With AI And Enhanced Lab Accessibility

Thermo Fisher Scientific has introduced the Thermo Scientific™ Glacios™ 3 Cryo-TEM, a next-generation cryogenic transmission electron microscope designed to advance structural biology research. The new system enhances 200 kV imaging capabilities, offering researchers improved clarity and accessibility across a wider range of laboratory environments.

Cryogenic electron microscopy (cryo-EM), which involves flash-freezing biomolecules to study them in their natural state, plays a crucial role in structure-based drug design. The Glacios 3 system builds on this technology, supporting research that has contributed to the development of RSV vaccines, GLP-1 therapies, and ongoing HIV vaccine discovery.

“When first presented with news of the Glacios 3, I was delighted to learn of the latest developments on its platform,” said Dr. Steve Smerdon, a professor of structural biology in the University of Birmingham Department of Cancer and Genomic Sciences. “The improvements to the enclosure are particularly impressive, as they will allow greater flexibility in choosing a site for the instrument with potentially substantial reductions in refurbishment and running costs.”

The instrument features the Thermo Scientific™ READY™ System, which minimizes vibrations and environmental disruptions, allowing easier installation without extensive lab modifications. In addition, AI-driven software enhances workflow efficiency, boosting throughput and improving data quality compared to earlier platforms.

“The Glacios 3 Cryo-TEM opens the door for more institutions and researchers to harness the capabilities of cryo-EM, helping them tackle complex biological questions and enhance therapeutic development,” said Steve Reyntjens, Thermo Fisher Scientific vice president and general manager of life sciences. “This combination of advanced instrumentation and AI-powered workflows represents a step change in how scientists generate insights, which will accelerate the development of life-improving treatments.”

Further design improvements focus on usability and productivity, including better sample handling and contamination control. The system supports advanced cryo-EM techniques, including single-particle analysis, cryo-electron tomography, and microcrystal electron diffraction, expanding its utility across diverse research applications.

Ad
Advertisement